12:00 AM
 | 
Mar 08, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Oxis regulatory update

OXIS subsidiary Oxis Therapeutics Inc. received notice of allowance for a U.S. patent claiming...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >